Impact of course of therapy on response rate and duration with the Bexxar® therapeutic regimen (tositumomab and iodine I 131 tositumomab) and with chemotherapy Meeting Abstract


Authors: Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Kaminski, M. S.
Abstract Title: Impact of course of therapy on response rate and duration with the Bexxar® therapeutic regimen (tositumomab and iodine I 131 tositumomab) and with chemotherapy
Meeting Title: 46th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 104
Issue: 11 Pt. 1
Meeting Dates: 2004 Dec 4-7
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2004-11-16
Start Page: 41A
Language: English
ACCESSION: WOS:000225127500135
PROVIDER: wos
PUBMED: 15562524
DOI: 10.1182/blood.V104.11.132.132
Notes: Meeting Abstract: 132 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    781 Zelenetz